Iri05 0002 01
Chemical structure of irinotecan hydrochloride trihydrate showing the molecular formula C33H38N4O6·HCl·3H2O and molecular weight 677.19.*
Irinotecan Hydrochloride Injection, Solution
Product Images NDC 63323-193
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Irinotecan Hydrochloride (NDC 63323-193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Iri05 0002 02
A Kaplan-Meier survival curve comparing the probability of survival over time in months between patients treated with Irinotecan and a best supportive care (BSC) group. The chart includes median follow-up and median survival times for each group, with a p-value indicating statistical significance of the difference.*
Iri05 0002 03
A survival probability graph comparing the effectiveness of Irinotecan versus 5-FU over a period of 21 months. The y-axis represents probability, while the x-axis shows time in months, illustrating a higher survival probability trend for Irinotecan compared to 5-FU.*
Iri05 0002 04
Iri05 0002 05
Label for Irinotecan Hydrochloride Injection 40 mg per 2 mL (20 mg/mL) by Fresenius Kabi USA, LLC. The label indicates the drug is a single dose vial, must be diluted, is cytotoxic, and intended for intravenous use. NDC 63323-193-52 is displayed along with a barcode and lot/expiration information.*
Iri05 0002 06
Label for Irinotecan Hydrochloride Injection 40 mg per 2 mL (20 mg per mL) by Fresenius Kabi USA, LLC. The label includes warnings that it is a cytotoxic agent, instructions that it must be diluted, and storage conditions. It indicates a 2 mL single dose vial with barcodes and the labeler location in Lake Zurich, Illinois.*
Iri05 0002 07
Label for Irinotecan Hydrochloride Injection 20 mg/mL by Fresenius Kabi USA, in a 5 mL single dose vial. The label states a dose of 100 mg per 5 mL and highlights it is a cytotoxic agent for intravenous use that must be diluted. Storage instructions indicate to keep at 20° to 25°C and protect from freezing.*
Iri05 0002 08
Label for Irinotecan Hydrochloride Injection, 100 mg per 5 mL (20 mg per mL), from Fresenius Kabi USA, LLC. The label includes product identification, concentration, barcode, storage instructions, and handling warnings identifying it as a cytotoxic agent. It specifies a 5 mL single-dose vial and provides additional details about composition, pH adjustment, and usage instructions.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
